Method of treating subject infected with Neisseria gonorrhea

Details Method of treating subject infected with Neisseria gonorrhea Method of treating subject infected with Neisseria gonorrhea

2006-08-22

2006-08-22

Kwon, Brian-Yong S. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

C-o-group doai

C514S731000, C514S734000

Reexamination Certificate

active

07094809

ABSTRACT:
The present invention provides a method of inhibiting the formation of infectious herpes virus particles, particularly infectious herpes simplex virus (HSV) particles, in a host cell. The method involves administering an effective amount of a hydroxylated tolan, particularly a polyhydroxylated tolan, to a herpes virus infected host cell. The present invention also provides a method of treating a herpes virus infection, particularly an HSV infection. The method comprises administering a topical composition comprising a therapeutically effective amount of a hydroxylated tolan to a herpes virus-infected site. The present invention also relates to a topical composition for treating a herpes virus infection selected from the group consisting of an HSV infection, a cytomegalovirus infection, and a varicella zoster virus infection. The present invention also provides a method of treating a subject infected withNeisseria gonorrhea.

REFERENCES:
patent: 3928399 (1975-12-01), Couttet et al.
patent: 4001137 (1977-01-01), Steinstrasser
patent: 4153509 (1979-05-01), Schwartz
patent: 5420361 (1995-05-01), Grund
patent: 5470728 (1995-11-01), Grund
patent: 6197834 (2001-03-01), Docherty
patent: 6355692 (2002-03-01), Docherty
patent: 6599945 (2003-07-01), Docherty et al.
patent: 280030 (1990-08-01), None
“Antibiotic Disk Suceptiblity Tests withNeisseria Gonorrhea”, Maier et al., Antimicrobial Agents and Chemotherapy, Mar. 1974, p. 210-216.
“Resveretrol inhibition of herpes simplex virus replication” by Docherty, et al.,Antiviral Research, 43 (1999) pp. 145-155.
“Resveretrol selectively inhibitsNeisseria gonorrheaeandNeisseria meningitidis” by Docherty, et al.,Journal of Antimicrobial Chemotherapy, 47:243-244, Feb. 2001.
“Resveretrol inhibits the growth ofHelicobacter pylori in Vitro” by Mahady, et al,American Journal of Gastroenterology, 95:1849, Jul. 2000.
“Antibacterial Constituents ofFicus barteriFruits” by Ogungbamila, et al.,International Journal of Pharmacognosy, vol. 35, No. 3, 1997, pp. 185-189.
Abstract 767 “Inhibition of HSV-1 Replication by Polyphenol Analogs” by Lesniewski, et al., 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, Sep. 17-20, 2000.
Abstract 86 “Hydroxytolan Analog Inhibition of HSV-1 Replication” by Lesniewski, et al., Fourteenth International Conference on Antiviral Research, Seattle, Washington, Apr. 8-12, 2001.
“In Vivo and In Vitro Antiherptic Effects of Polyphenols” by Lesniewski, et al., 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, Dec. 16-19, 2001.

Affiliated with

Also associated with

Rating

Method of treating subject infected with Neisseria gonorrhea does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating subject infected with Neisseria gonorrhea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating subject infected with Neisseria gonorrhea will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3622266